Anti-vascular endothelial growth factor agents reduce macular edema and improve vision in
eyes with macular edema associated with retinal vein occlusion (RVO), including branch …

Background: Retinal vein occlusion is the second most common retinal vascular disorder
after diabetic retinopathy and is considered to be an important cause of visual loss. In this …

Purpose To evaluate the effects of repeated intravitreal injections of bevacizumab (IVB)
versus triamcinolone acetonide (IVT) in the treatment of acute central retinal vein occlusion …

Purpose To assess the effectiveness and safety of intravitreal ranibizumab compared with
bevacizumab for the treatment of macular edema associated with branch retinal vein …

Purpose: To evaluate microperimetry changes in patients with acute macular edema
secondary to branch retinal vein occlusion during a follow-up period of 12 months with …

Purpose The aim of this study was to evaluate the cost effectiveness of ranibizumab
compared with verteporfin photodynamic therapy (vPDT) or no treatment (observation) in …

Purpose: To investigate the outcome of intravitreal ranibizumab and/or dexamethasone
implant treatment for treatment of macular edema (ME) secondary to central or branch retinal …

Background We wanted to determine whether multiple injections of intravitreal ranibizumab
was associated with an elevated intraocular pressure (IOP) in patients treated for …

Background In this meta-analysis, the outcome was analysed of intravitreal anti-VEGF
(vascular endothelial growth factor) ocular therapy of macular oedema secondary to branch …

目的观察玻璃体内注射Lucentis 治疗视网膜静脉阻塞继发黄斑水肿的疗效. 方法回顾分析2014
年3 月~ 2015 年3 月就诊于眼科门诊的视网膜静脉阻塞继发黄斑水肿患者27 例28 眼 …